Lv1
20 积分 2023-06-12 加入
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
1个月前
已完结
Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
2个月前
已完结
Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non–small-cell Lung Cancer
3个月前
已完结
PL02.09 Aumolertinib plus Chemotherapy for NSCLC with EGFR and Concomitant Tumor Suppressor Genes (ACROSS 2): Phase III study
6个月前
已关闭
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
6个月前
已完结
Four novel RECQL4 mutations in four Chinese patients with Rothmund-Thomson syndrome and analysis of RECQL4 mRNA expression level in one typical patient
7个月前
已完结
A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC): Genomic sequencing and updated efficacy results
8个月前
已完结
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
8个月前
已完结
Gene of the month:PIK3CA
8个月前
已完结
PIK3CA in cancer: The past 30 years
8个月前
已完结
皖公网安备34019202002308
